Position in GERN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,374
-$5,829 QoQ
Shares Held
13,574
-12.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 259 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. GERN ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in GERN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,374 | 13,574 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $23,203 | 15,573 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,924 | 13,579 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,118 | 14,685 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $20,291 | 14,391 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $24,493 | 15,405 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,423 | 14,244 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $65,525 | 14,433 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,642 | 11,944 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $33,541 | 10,164 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,920 | 17,498 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $43,953 | 20,733 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $91,067 | 28,370 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $45,682 | 21,052 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $7,329 | 4,729 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $3,536 | 2,600 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,200 | 2,623 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,593 | 2,623 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,970 | 5,653 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $26,896 | 17,023 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,216 | 2,023 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,480 | 2,000 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $4,410 | 2,023 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||